Chinese Journal of Hepatology 2004 Issue 2 Influence factors and predictors in anti-viral therapy for chronic hepatitis C

Influence factors and predictors in anti-viral therapy for chronic hepatitis C
jin sheng ; zhou wei ping ; zhang da zhi

..............page:124-125

Advance in research of anti-HBV and anti-HCV through RNAi
cai da chuan ; ren hong

..............page:126-128

..............page:66

2004 nian du zhong hua yi xue hui gan zang bing xue fen hui zhong hua gan zang bing za zhi zhong qing nian gan bing ge lan su shi ke lin chuang ke yan ke ti ji jin ji you xiu lin chuang lun wen kai shi shen bao

..............page:插页

Some factors on hepatic steilate cells activation
yang wei feng ; chen hou chang ; jiang yi ping

..............page:121-123

Review of recent research on hepatitis C therapy for 54th annual meeting of the American association for the study of liver diseases
wei lai

..............page:118-120

Assessment of Chinese references in viral hepatitis treated with prostaglandin E
luo rui hong ; yao ji lu ; zhao zhi xin ; mei yong yu

..............page:116-117

The imaging diagnosis of tumor-like multi-nodule fatty liver
wang zhong qiu ; ji xue man ; xu jian ; chen zi qian ; lu guang ming ; li jie shou

..............page:114-115

Clinical analysis on six cases of hepatic myclopathy
kong li ; ren zhong xuan ; zhang su huan

..............page:107-107

Risk factors analysis for cirrhosis patients with upper digestive tract blooding
li hai rong ; zhu gan

..............page:120-120

Effects of estradiol on the proliferation and activation of cultured rat hepatic stellate cells
fan zhen ; lv min he ; zhao you an ; liu fu li ; cui yi ; li yan qing ; wang chun xia

..............page:113-114

Relationship between negative life event and liver-function in patients with hepatitis B
wan bao mei ; liu shu jun ; yan hong feng ; tan yong xing ; yin yan ming

..............page:112-113

The effect of the Ca2+ inside platelet through adding glycocine deoxycholic acid
tang zhong ; zhou jing guo ; huang wen fang ; guo xiao lan

..............page:111-112

Expression of p27,Cyclin A in hepatocellular carcinoma and its clinical significance
zhou qi ; wang guang tian ; liang li jian ; zheng wei ; pang zhi gang

..............page:110-110

The expression of liver tissue renin-angiotensin system mRNA in patients with chronic hepatitis and liver cirrhosis
song huai yu ; han li hui ; zhu ju ren

..............page:109-109

The changes and the significance of soluble complement receptor type 1 in serum of patients with hepatitis gravis
dong ge feng ; liu dian yong ; wang jing bo ; xu bai quan ; wang hai bin

..............page:108-109

Expression of angiotensin Ⅱ type 1 receptor in the procession of hepatic fibrosis
wang wei wei ; yang xi shan ; wang jie ; li xu

..............page:91-91

Protective effect of glutathione on the ischemia-reperfusion injury of liver cirrhosis patients with massive upper gastrointestinal hemorrhage
he shui xiang ; qiao wen ; zuo xin ming ; wang shu ying ; li hong xia

..............page:78-78

Evaluation of molecular absorbent re-circulative system in he patic encephaiopathy treatment by Glasgow scores
yang xiao lan ; zhong yuan bin ; cheng na ; he jiang long

..............page:75-75

Research on hepatitis C is importance in China
wang yu ming

..............page:106-107

Antiviral therapy for hepatitis C
hou jin lin ; sun jian

..............page:105-105

Diagnostic tests for hepatitis C
yang dong liang

..............page:104-104

Diversity of clinical manifestation of chronic hepatitis C
cheng jun

..............page:103-103

Natural history of hepatitis C
wei lai

..............page:102-102

Transfection of human hepatic stimulator substance gene could protect BEL-7402 cells against hepatotoxins
chen li ; sun hong liu ; yang lin ; du hai jun ; an wei

..............page:99-101

Establishment of human hepatocellular carcinoma multidrug-resistance cell line (HepG2/Adm) and study apoptosis induced by low-frequency pulse ultrasound exposure
di bao jin ; wu feng ; shao ze yong ; hu kai ; zhao chun liang ; wang zhi biao

..............page:95-98

Clinical values of vascular endothelial growth factor expression and microvascular density analysis in liver cancer specimens
yao deng fu ; zhu yong ; wu xin hua ; wu zuo ; qiu li wei

..............page:92-94

The construction of transferrin receptor-mediated HSV-TK gene transfer system and its effect on human hepatocellular carcinoma cells in vitro
yang dao feng ; zhu hui fen ; shen guan xin ; tian de ying

..............page:88-91

Reversal of multidrug resistance gene MDR1 and MRP of drug-resistant human hepatocellular carcinoma cells SMMC-7721/ADM with antisense phosphorothioate oligonucleotides
luo hua you ; yang jia yin ; liu zi ming ; lin zuo yuan ; yan lv nan

..............page:85-87

Towards research on hepatitis C
zhuang hui

..............page:65-66

Impaired non-viral specific immune function of dendritic cell does not interfere with clearance and cytotoxic T lymphocyte response to HBV or HCV
fan chun lei ; chen hong song ; li ruo bing ; wang song xia ; cong xu ; fei ran ; jiang dong ; wang yu ; wei lai

..............page:67-71

The influence of HCV genotype on the IFN treatment of patients with chronic hepatitis C
xie yao ; xu dao zhen ; lu zhi meng ; luo kang xian ; jia ji dong ; wang yu ming ; zhao gui zhen ; zhang shu lin ; zhang da zhi

..............page:72-75

HCV RNA in PBMC as predictor of the response to antiviral therapy in chronic hepatitis C
xu dao zhen ; li zheng qin ; xie yao

..............page:76-78

Enhancement of a hepatitis B DNA vaccine potency using aluminum phosphate in mice
liang zeng wei ; ren hong ; lan ying hua ; li yong guo

..............page:79-81

The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B
wu xi run ; wang zuo ; shi shui sheng ; lv min he ; guo wen dong

..............page:82-84